Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2, offering comprehensive inhibition with a mechanism and pharmacokinetics differentiated from other therapies. The Phase 3 VIKTORIA-1 trial, evaluating gedatolisib with fulvestrant, with or without palbociclib, in HR+/HER2- breast cancer, has completed enrollment and reported results for PIK3CA WT tumors, with cohort 2 (PIK3CA MT) also enrolled. Phase 3 VIKTORIA-2 and Phase 1b/2 CELC-G-201 trials, evaluating combinations in endocrine-resistant HR+/HER2- breast cancer and metastatic castration-resistant prostate cancer, are ongoing.

What symbol and exchange does Celcuity shares trade?

Celcuity trades on the NASDAQ stock market under the symbol CELC.

What is Celcuity stock price doing today?

As of October 30, 2026, CELC stock price declined to $69.13 with 626,781 million shares trading.

What is Celcuity's Beta?

CELC has a beta of 2.59, meaning it tends to be more sensitive to market movements. CELC has a correlation of 0.17 to the broad based SPY ETF.

How much is Celcuity worth?

CELC has a market cap of $3.38 billion. This is considered a Mid Cap stock.

How much money does Celcuity make?

Last quarter Celcuity reported $0 in Revenue and -$1.07 earnings per share. This fell short of revenue expectation by $-400,000 and exceeded earnings estimates by $.01.

What is the highest and lowest price Celcuity traded in the last 3 year period?

In the last 3 years, CELC traded as high as $151.02 and as low as $7.58.

What are the top ETFs holding Celcuity?

The top ETF exchange traded funds that CELC belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWO.

Is Celcuity (CELC) a good investment?

CELC has underperformed the market in the last year with a return of -6.6%, while the SPY ETF gained +11.0%. In the last 3 month period, CELC fell short of the market, returning -17.0%, while SPY returned +3.9%. However, in the most recent 2 weeks CELC has outperformed the stock market by returning +14.6%, while SPY returned -2.1%.

What are the support and resistance levels for Celcuity (CELC)?

CELC support price is $66.41 and resistance is $72.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELC shares will trade within this expected range on the day.